None listed
Conditions
Brief summary
Background: The surgical pleth index (SPI, GE Healthcare, Helsinki, Finland) is a 0-100 score derived from the intraoperative non-invasive monitoring of oxygen saturation. Simply speaking, SPI is a software using existing data. The SPI score claims to reflect states of intraoperative pain. A previous investigation by us published in the British Journal of Anaesthesia (Br J Anaesth. 2016 Sep;117(3):371-4) found that a SPI > 30 at the end of surgery (prior to awakening) predicted moderate-severe postoperative pain. Objectives: As such prediction would provide a significant benefit for the pre-emptive treatment of pain, the proposed project aims to prospectively validate the SPI cut-off published by us in a larger cohort. In addition, we would like to evaluate the influence of age on the SPI cut-off value predicting moderate-severe pain, as well as the influence of a different anaesthetic technique (total intravenous anaesthesia) on the predictive value of SPI. The latter sub-group will be investigated by our collaborators in Kiel, Germany. Within WA Health 200 patients scheduled for non-emergency surgery under sevoflurane/opioid anaesthesia will be included in the study. Patients will receive a completely standard anaesthetic. At the end of surgery, SPI will be recorded minutely for 5 minutes. As outlined above, this simply requires recording of displayed SPI values. As SPI uses available data derived from standard monitoring, no discomfort or risk is associated with study inclusion. After awakening, 3 pain scores (numeric rating scales 0-10) will be recorded in the recovery room. The 5-minutely recording of pain scores is standard protocol in the involved hospitals and does hence not at all inconvenience patients. Apart from SPI and pain readings, only very limited data are recorded.
Interventions
Sponsors
Eligibility
Inclusion criteria
Patients aged 18-100 yrs. scheduled for anaesthesia (non emergency) with sevoflurane/opioid.
Exclusion criteria
Regular or intraoperative medication (prior to SPI assessment) known or suspected to interact with the assessment of SPI (i.e. ketamine, clonidine, neostigmine, beta-receptor blockers, incl. metaraminol/ephedrine within 10 minutes of the SPI assessment), pacemaker, severe autonomous dysfunction, significant cardiac arrhythmia (i.e. AF), Aboriginal patients, patients with an impaired ability to rate their level of postoperative pain on a NRS (i.e. significant mental impairment, dementia), surgical tourniquet at the time of and/or < 10 minutes prior to SPI assessment, any analgesic medication between SPI assessment and first pain score in the recovery room (note: extremely rare)